These changes were likewise observed in the allergen immunotherapy groups: in those treated with low-dose SLIT, a significant decline in erythrocyte counts, hematocrit (p < 0.01, respectively) and hemoglobin (p < 0.05) was found similar to those treated with high-dose SLIT who had significantly lower erythrocyte counts and MCH levels (p < 0.05) after allergen challenge while the hematocrit did not reach statistical significance (p = 0.052).
← all excerpts
Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis.
1
0.0520
0.0520